Nath Bio-Genes (I) Ltd

Nath Bio-Genes maintains a conservative capital structure with a debt-to-equity ratio of 0.19, significantly below the median for the Fishing & Farming industry. The company holds INR 870.5 million in cash and equivalents, but net cash is negative after subtracting total debt, indicating potential liquidity constraints. The current ratio of 1.89 suggests adequate short-term liquidity to cover obligations, though the company's operating cash flow of INR 175.8 million is modest relative to its asset base. Profitability metrics show a return on equity of 5.99% and return on assets of 3.76%, both below the industry median for the Fishing & Farming sector. Gross profit of INR 2.52 billion represents 69% of revenue, but operating income of INR 475.6 million and net income of INR 386.0 million indicate pressure from operating expenses. The company's operating margin of 13.04% is below the industry median, suggesting inefficiencies in cost control or pricing power. The company's revenue is concentrated in India, with no disclosed international operations. Segment-wise, the field crops and vegetable crops categories are the primary revenue drivers, though the input data does not provide a breakdown of geographic or segment revenue contributions. The company's exposure to domestic agricultural demand and regulatory changes in seed production and GM crop approvals could impact its revenue stability. Outlook for the current fiscal year shows a projected revenue growth of 8.2%, with a 12.4% increase expected in the following year. This growth is driven by expansion in the vegetable crop and plant nutrition segments, supported by increasing demand for high-yield seeds and soil health products. However, the company's capital expenditure of INR 79.2 million in the latest period suggests limited reinvestment in growth. The risk assessment highlights medium liquidity risk due to the negative net cash position and low dilution risk, with no near-term pressure from share issuance. The company's free cash flow of INR 306.9 million provides some flexibility, but the absence of a detailed dilution risk analysis in the input data limits further assessment. Regulatory and geopolitical risks are not explicitly quantified in the input data, but the company's operations are subject to Indian agricultural policies and GM crop regulations. Recent filings and transcripts indicate no material events in the past 90 days. The company's 10-K filing from the previous fiscal year outlines ongoing research and development in hybrid seed varieties, but no new product launches or strategic acquisitions were disclosed.